Attention Deficit and Disruptive Behavior Disorders  >>  Intuniv (guanfacine XR)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Intuniv (guanfacine XR) / Shionogi, Takeda
NCT01156051: Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia

Terminated
4
29
US
Guanfacine extended-release tablets, Intuniv (TM), guanfacine HCl, SPD503, Placebo comparator, "sugar pill"
Children's Specialized Hospital, Shire
Attention-Deficit/Hyperactivity Disorder, Attention Deficit Disorder, Insomnia, Sleep Disorders
02/12
02/12
NCT01177306: Inuniv and Working Memory

Completed
4
18
US
extended release guanfacine, Intuniv, Serial Number 306, IND 63,551
Lori A. Schweickert, MD, Shire
Attention Deficit Hyperactivity Disorder
12/13
05/14
ADINT2012, NCT02141113: Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).

Completed
4
26
US
Guanfacine Hydrocholride, Intuniv
Rochester Center for Behavioral Medicine, Shire
Adult Attention-Deficit Hyperactivity Disorder
09/14
11/14
NCT02048241: Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder

Completed
4
11
US
Parent Management Training, PMT, Placebo, Intuniv, Extended release Guanfacine
New York State Psychiatric Institute, Shire
Intermittent Explosive Disorder, Childhood Aggression, Oppositional Defiant Disorder, Attention Deficit Disorder
11/14
12/14

Download Options